A cost-effective algorithm for the diagnosis of Hepatitis C virus infection and prediction of HCV viremia in Cameroon

Bossi, 2004, Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection, J. Clin. Virol., 30, 45, 10.1016/j.jcv.2003.08.007 Boyer, 2000, Pathogenesis, diagnosis and management of hepatitis C, J. Hepatol., 32, 98, 10.1016/S0168-8278(00)80419-5 Colin, 2001, Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature, J. Viral. Hepat., 8, 87, 10.1046/j.1365-2893.2001.00280.x Delaporte, 1994, Hepatitis C in remote populations of southern Cameroon, Ann. Trop. Med. Parasitol., 88, 97, 10.1080/00034983.1994.11812844 Dufour, 2003, Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection, Clin. Chem., 49, 479, 10.1373/49.3.479 Dufour, 2000, Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring, Clin. Chem., 46, 2050, 10.1093/clinchem/46.12.2050 Erensoy, 2001, Diagnosis of hepatitis C virus (HCV) infection and laboratory monitoring of its therapy, J. Clin. Virol., 21, 271, 10.1016/S1386-6532(00)00170-0 Kowo, 1995, Prevalence of hepatitis C virus and other blood-borne viruses in Pygmies and neighbouring Bantus in southern Cameroon, Trans. Roy. Soc. Trop. Med. Hyg., 89, 484, 10.1016/0035-9203(95)90076-4 Krajden, 2002, Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV Test Version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay, J. Clin. Microbiol., 40, 2903, 10.1128/JCM.40.8.2903-2907.2002 Louis, 1994, High prevalence of anti-hepatitis C virus antibodies in a Cameroon rural forest area, Trans. Roy. Soc. Trop. Med. Hyg., 88, 53, 10.1016/0035-9203(94)90494-4 Madhava, 2002, Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa, Lancet Infect. Dis., 2, 293, 10.1016/S1473-3099(02)00264-5 Mbanya, 2001, Transfusion outcome in a resource-limited setting of Cameroon: a five-year evaluation, Int. J. Infect. Dis., 5, 70, 10.1016/S1201-9712(01)90028-1 Morisco, 1998, Long-term observation of HCV-positive patients with normal ALT values: persistence of a clinically healthy state, Res. Virol., 149, 277, 10.1016/S0923-2516(99)89006-2 Ndjomou, 2002, Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon, J. Med. Virol., 66, 179, 10.1002/jmv.2128 Nerrienet, 2005, Hepatitis C virus infection in Cameroon: a cohort-effect, J. Med. Virol., 76, 208, 10.1002/jmv.20343 Njouom, 2003, High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon, J. Med. Virol., 71, 219, 10.1002/jmv.10473 Njouom, 2003, Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: prevalence, viremia, and genotypes, J. Med. Virol., 69, 384, 10.1002/jmv.10300 Pawlotsky, 2003, Use and interpretation of hepatitis C virus diagnostic assays, Clin. Liver Dis., 7, 127, 10.1016/S1089-3261(02)00064-8 Pawlotsky, 1998, What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?, Hepatology, 27, 1700, 10.1002/hep.510270632 Payan, 2003, Quantitative antibody analysis: use for the diagnosis of hepatitis C virus chronic infection, Ann. Biol. Clin., 61, 311 Richter, 2002, Laboratory assays for diagnosis and management of hepatitis C virus infection, J. Clin. Microbiol., 40, 4407, 10.1128/JCM.40.12.4407-4412.2002 Rouet, 2004, HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d’Ivoire: the ANRS 1236 study, J. Med. Virol., 74, 34, 10.1002/jmv.20143 World Health Organization, 1999, Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium, J. Viral. Hepat., 6, 35